Caribou Biosciences, Inc.

CRBU · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$149-$102-$99-$67
Dep. & Amort.$4$4$4$1
Deferred Tax$0$0-$0$0
Stock-Based Comp.$17$14$0$3
Change in WC-$5-$7-$4$29
Other Non-Cash-$5-$1$9$1
Operating Cash Flow-$138-$93-$91-$33
Investing Activities
PP&E Inv.-$5-$12-$6-$2
Net Acquisitions$0$0$0$0
Inv. Purchases-$304-$395-$339-$173
Inv. Sales/Matur.$397$338$253$0
Other Inv. Act.-$2$0-$1-$1
Investing Cash Flow$87-$68-$93-$176
Financing Activities
Debt Repay.$0$0$0$1
Stock Issued$15$153$2$321
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$2$2$0$111
Financing Cash Flow$17$154$2$433
Forex Effect$0$0$0$0
Net Chg. in Cash-$35-$7-$182$225
Supplemental Information
Beg. Cash$51$58$240$16
End Cash$16$51$58$240
Free Cash Flow-$145-$105-$97-$36